| Role of vitamin D in targeting cancer and cancer stem cell populations and its therapeutic implications JB Marigoudar, D Sarkar, YM Yuguda, RF Abutayeh, A Kaur, A Pati, ... Medical Oncology 40 (1), 2, 2022 | 8 | 2022 |
| In-silico analysis for the confirmation of insulin receptor as a target for reported GLUT4 anti-diabetic natural compounds YM Yuguda, R Pandey, MM Chavhan, D Mitra, A Vijay, S Ahmad, ... GSC Biological and Pharmaceutical Sciences 19 (2), 205-214, 2022 | 3 | 2022 |
| Production and in vitro studies of Bitter Gourd (Momodica charantia) seed protein hydrolysates with antidiabetic activity YM Yuguda GSC Biological and Pharmaceutical Sciences 22 (2), 222-233, 2023 | 2 | 2023 |
| Application of Next Generation Sequencing (NGS) technology in forensic science: A review YM Yuguda GSC Biological and Pharmaceutical Sciences 23 (2), 155-159, 2023 | 1 | 2023 |
| Impact of oral administration of bromelain-derived bitter gourd seed protein hydrolysate on some Hematological parameters in healthy Wister albino rats YM Yuguda, SM Bappah World Journal of Biology Pharmacy and Health Sciences 16 (3), 073-079, 2023 | | 2023 |
| Emerging trends in computational approaches for drug discovery in molecular biology YM Yuguda, IE Unuebho, J Dhanushya GSC Biological and Pharmaceutical Sciences 24 (3), 202-213, 2023 | | 2023 |
| Profiling and In vivo studies of Bromelain Bitter Gourd (Momodica charantia) seed protein hydrolysate with antidiabetic activity YM Yuguda GSC Biological and Pharmaceutical Sciences 23 (1), 269-276, 2023 | | 2023 |
| target non-small cell lung cancer (NSCLC) YM Yuguda, D Mitra, YD Kale, A Pati, M Negi, S Moin, JB Marigoudar, ... | | 2022 |
| In-silico study of potential antiviral drug compounds against EGFR kinase domain to target non-small cell lung cancer (NSCLC) YM Yuguda, D Mitra, YD Kale, A Pati, M Negi, SM Uddin, ML Daya, ... GSC Biological and Pharmaceutical Sciences 21 (1), 129-143, 2022 | | 2022 |
